Literature DB >> 18097687

Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Mark F Stinski1, Hiroki Isomura.   

Abstract

The cytomegalovirus (CMV) major immediate early (MIE) enhancer-containing promoter regulates the expression of the downstream MIE genes, which have critical roles in reactivation from latency and acute infection. The enhancer consists of binding sites for cellular transcription factors that are repeated multiple times. The primate and nonprimate CMV enhancers can substitute for one another. The enhancers are not functionally equivalent, but they do have overlapping activities. The CMV MIE enhancers are located between divergent promoters where the leftward genes are critical and essential for reactivation from latency and acute infection and the rightward gene is nonessential. The rightward transcription unit is controlled by an enhancer for murine CMV. In contrast, human CMV has a set of repressor elements that prevents enhancer effects on the rightward viral promoter. The human CMV enhancer that controls the leftward transcription unit has a distal component that is nonessential at high multiplicity of infection (MOI), but has a significant impact on the MIE gene expression at low MOI. The proximal enhancer influences directly the level of transcription of the MIE genes and contains an essential Sp-1 site. The MIE promoter has a site adjacent to the transcription start site that is essential at the earliest stage of infection. The MIE enhancer-containing promoter responds to signal transduction events and to cellular differentiation. The role of the CMV MIE enhancer-containing promoter in acute infection and reactivation from latency are reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097687     DOI: 10.1007/s00430-007-0069-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  89 in total

1.  In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus.

Authors:  N K Grzimek; J Podlech; H P Steffens; R Holtappels; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.

Authors:  Charles H Cook; Joanne Trgovcich; Peter D Zimmerman; Yingxue Zhang; Daniel D Sedmak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Core promoter specificities of the Sp1 and VP16 transcriptional activation domains.

Authors:  K H Emami; W W Navarre; S T Smale
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

5.  Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter.

Authors:  Philip E Lashmit; Christopher A Lundquist; Jeffery L Meier; Mark F Stinski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.

Authors:  Christian O Simon; Birgit Kühnapfel; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

7.  Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro.

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

8.  The Maastricht strain and England strain of rat cytomegalovirus represent different betaherpesvirus species rather than strains.

Authors:  P S Beisser; S J Kaptein; E Beuken; C A Bruggeman; C Vink
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

9.  Cellular homeoproteins, SATB1 and CDP, bind to the unique region between the human cytomegalovirus UL127 and major immediate-early genes.

Authors:  Jialing Lee; Zachary Klase; Xiaoqi Gao; Jeremy S Caldwell; Mark F Stinski; Fatah Kashanchi; Sheng-Hao Chao
Journal:  Virology       Date:  2007-05-18       Impact factor: 3.616

10.  The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.

Authors:  Maciej T Nogalski; Jagat P Podduturi; Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

View more
  54 in total

1.  Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth.

Authors:  Jürgen Podlech; Rares Pintea; Kai A Kropp; Annette Fink; Niels A W Lemmermann; Katja C Erlach; Elena Isern; Ana Angulo; Peter Ghazal; Matthias J Reddehase
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

2.  Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

Authors:  Ileana M Cristea; Nathaniel J Moorman; Scott S Terhune; Christian D Cuevas; Erin S O'Keefe; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Giulia Muratore; Serena Massari; Maria Elena Terlizzi; Oriana Tabarrini; Giorgio Gribaudo; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 4.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

5.  Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

6.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

7.  Deletion of the rat cytomegalovirus immediate-early 1 gene results in a virus capable of establishing latency, but with lower levels of acute virus replication and latency that compromise reactivation efficiency.

Authors:  Gordon R Sandford; Uwe Schumacher; Jakob Ettinger; Wolfram Brune; Gary S Hayward; William H Burns; Sebastian Voigt
Journal:  J Gen Virol       Date:  2009-11-18       Impact factor: 3.891

8.  Attenuated protein expression vectors for use in siRNA rescue experiments.

Authors:  Eiji Morita; Jun Arii; Devin Christensen; Jörg Votteler; Wesley I Sundquist
Journal:  Biotechniques       Date:  2012-08       Impact factor: 1.993

9.  A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication.

Authors:  Kareni J Perez; Francisco Puerta Martínez; Ruth Cosme-Cruz; Neysa M Perez-Crespo; Qiyi Tang
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Roles of polypyrimidine tract binding proteins in major immediate-early gene expression and viral replication of human cytomegalovirus.

Authors:  Ruth S Cruz Cosme; Yasuhiro Yamamura; Qiyi Tang
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.